These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12808206)

  • 21. Results of molecular diagnostic assays targeting feline herpesvirus-1 and feline calicivirus in adult cats administered modified live vaccines.
    Ruch-Gallie RA; Veir JK; Hawley JR; Lappin MR
    J Feline Med Surg; 2011 Aug; 13(8):541-5. PubMed ID: 21439879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunisation with a combination of two complementary feline calicivirus strains induces a broad cross-protection against heterologous challenges.
    Poulet H; Brunet S; Leroy V; Chappuis G
    Vet Microbiol; 2005 Mar; 106(1-2):17-31. PubMed ID: 15737470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens.
    Kanellos T; Sutton DJ; Salisbury CF; Chalmers WS
    J Feline Med Surg; 2008 Aug; 10(4):346-54. PubMed ID: 18448375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of maternally-derived antibodies on serologic responses to vaccination in kittens.
    Digangi BA; Levy JK; Griffin B; Reese MJ; Dingman PA; Tucker SJ; Dubovi EJ
    J Feline Med Surg; 2012 Feb; 14(2):118-23. PubMed ID: 22314087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease.
    Huang C; Hess J; Gill M; Hustead D
    J Feline Med Surg; 2010 Feb; 12(2):129-37. PubMed ID: 19836282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of intranasal administration of a modified live feline herpesvirus 1 and feline calicivirus vaccine against disease caused by Bordetella bronchiseptica after experimental challenge.
    Bradley A; Kinyon J; Frana T; Bolte D; Hyatt DR; Lappin MR
    J Vet Intern Med; 2012; 26(5):1121-5. PubMed ID: 22860699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal immunization with inactivated feline calicivirus particles confers robust protection against homologous virus and suppression against heterologous virus in cats.
    Sato H; Sehata G; Okada N; Iwamoto K; Masubuchi K; Kainuma R; Noda T; Igarashi T; Sawada T; Noro T; Oishi E
    J Gen Virol; 2017 Jul; 98(7):1730-1738. PubMed ID: 28691897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of passively transferred antibodies in cats with acute viral upper respiratory tract infection.
    Friedl Y; Schulz B; Knebl A; Helps C; Truyen U; Hartmann K
    Vet J; 2014 Sep; 201(3):316-21. PubMed ID: 24929533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-year duration of immunity in cats following vaccination against feline rhinotracheitis virus, feline calicivirus, and feline panleukopenia virus.
    Gore TC; Lakshmanan N; Williams JR; Jirjis FF; Chester ST; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):213-22. PubMed ID: 17039444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of tri-combinant vaccine for feline herpesvirus, calicivirus and panleukopenia virus infections in Japanese native cats.
    Yagami K; Furukawa T; Fukui M; Hamada H
    Jikken Dobutsu; 1985 Jul; 34(3):287-94. PubMed ID: 2998830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms for persistence of acute and chronic feline calicivirus infections in the face of vaccination.
    Pedersen NC; Hawkins KF
    Vet Microbiol; 1995 Nov; 47(1-2):141-56. PubMed ID: 8604546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody Response to Feline Calicivirus Vaccination in Healthy Adult Cats.
    Bergmann M; Speck S; Rieger A; Truyen U; Hartmann K
    Viruses; 2019 Jul; 11(8):. PubMed ID: 31370359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential for broad-spectrum protection against feline calicivirus using an attenuated myxoma virus expressing a chimeric FCV capsid protein.
    McCabe VJ; Spibey N
    Vaccine; 2005 Nov; 23(46-47):5380-8. PubMed ID: 16176851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of feline upper respiratory tract disease with reference to prevalence and risk factors for infection with feline calicivirus and feline herpesvirus.
    Binns SH; Dawson S; Speakman AJ; Cuevas LE; Hart CA; Gaskell CJ; Morgan KL; Gaskell RM
    J Feline Med Surg; 2000 Sep; 2(3):123-33. PubMed ID: 11716607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A field trial to assess the effect of vaccination against feline herpesvirus, feline calicivirus and feline panleucopenia virus in 6-week-old kittens.
    Dawson S; Willoughby K; Gaskell RM; Wood G; Chalmers WS
    J Feline Med Surg; 2001 Mar; 3(1):17-22. PubMed ID: 11716626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant feline herpesvirus type 1 expressing immunogenic proteins inducible virus neutralizing antibody against feline calicivirus in cats.
    Yokoyama N; Maeda K; Tohya Y; Kawaguchi Y; Fujita K; Mikami T
    Vaccine; 1996 Dec; 14(17-18):1657-63. PubMed ID: 9032896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries.
    Helps CR; Lait P; Damhuis A; Björnehammar U; Bolta D; Brovida C; Chabanne L; Egberink H; Ferrand G; Fontbonne A; Pennisi MG; Gruffydd-Jones T; Gunn-Moore D; Hartmann K; Lutz H; Malandain E; Möstl K; Stengel C; Harbour DA; Graat EA
    Vet Rec; 2005 May; 156(21):669-73. PubMed ID: 15908495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assembly of feline calicivirus-like particle and its immunogenicity.
    Di Martino B; Marsilio F; Roy P
    Vet Microbiol; 2007 Feb; 120(1-2):173-8. PubMed ID: 17126499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of protective antibody titers against feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus in shelter cats using a point-of-care ELISA.
    Digangi BA; Gray LK; Levy JK; Dubovi EJ; Tucker SJ
    J Feline Med Surg; 2011 Dec; 13(12):912-8. PubMed ID: 21885311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of acute viral feline upper respiratory tract infections].
    Bergmann M; Ballin A; Schulz B; Dörfelt R; Hartmann K
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2019 Apr; 47(2):98-109. PubMed ID: 31013527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.